| YGL217C |
Saccharomyces cerevisiae |
|
YGL217C is differentially expressed in 10 experiments [15 up/13 dn]: 3 compound treatments: doxycycline [1 up/0 dn], none [0 up/1 dn], ...; 4 developmental stages: mitotic growth [0 up/1 dn], meiotic development [1 up/0 dn], ...; 9 genotypes, 4 growth conditions, 4 strain or lines and 1 other conditions. |
| YGL217C |
|
|
|
P53085
|
|
|
|
YGL217C
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Wild_type
|
Genotype |
|
|
Mitotic growth
|
Developmental stage |
|
|
Meiotic development
|
Developmental stage |
|
|
SPII media
|
Growth condition |
|
|
Abf1-1 hypomorph, homozygous
|
Genotype |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
GAL-ABF1 overexpression transg...
|
Genotype |
|
|
Commercial dry active yeast
|
Strain or line |
|
|
BY4743
|
Strain or line |
|
|
Doxycycline
|
Compound treatment |
|
|
None
|
Compound treatment |
|
|
25 degree_C
|
Temperature |
|
|
YPA media
|
Growth condition |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
Rpd3Δ H4(K5,8,12,16Q)
|
Genotype |
|
|
NSY438
|
Strain or line |
|
|
Rehydration
|
Growth condition |
|
|
YPD media
|
Growth condition |
|
|
CY2-4C
|
Strain or line |
|
|
H3(K4,9,14,18,23,27Q)
|
Genotype |
|
|
33 degree_C
|
Temperature |
|
|
Sodium chloride
|
Compound treatment |
|
|
H4 Δ2-26
|
Genotype |
|
|
Premeiosis
|
Developmental stage |
|
|
Meiotic prophase
|
Developmental stage |
|
|
Leu3(41,2621)::loxP-Kan-loxP
|
Genotype |
|
|
|
|
|
Processing time: 0.026 secs.